ScoreWhy is CorMedix, Inc. ?
1
With a growth in Net Profit of 175.33%, the company declared Very Positive results in Mar 26
- The company has declared positive results for the last 7 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD 197.69 MM
- NET PROFIT(HY) At USD 58.45 MM has Grown at 71.36%
- NET SALES(Q) At USD 127.43 MM has Grown at 63.52%
2
With ROE of 40.17%, it has a very attractive valuation with a 1.31 Price to Book Value
- Over the past year, while the stock has generated a return of -46.63%, its profits have risen by 1008.1%
3
High Institutional Holdings at 80.13%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
- Their stake has increased by 9.03% over the previous quarter.
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to CorMedix, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is CorMedix, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
CorMedix, Inc.
-46.63%
0.71
63.59%
S&P 500
20.78%
1.56
13.28%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
215.47%
EBIT Growth (5y)
49.69%
EBIT to Interest (avg)
-25.91
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.67
Sales to Capital Employed (avg)
0.39
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
80.13%
ROCE (avg)
7.71%
ROE (avg)
2.99%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
3
Industry P/E
Price to Book Value
1.31
EV to EBIT
3.51
EV to EBITDA
3.20
EV to Capital Employed
1.31
EV to Sales
1.69
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
37.33%
ROE (Latest)
40.17%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend32What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 197.69 MM
NET PROFIT(HY)
At USD 58.45 MM has Grown at 71.36%
NET SALES(Q)
At USD 127.43 MM has Grown at 63.52%
INTEREST COVERAGE RATIO(Q)
The company hardly has any interest cost
CASH AND EQV(HY)
Highest at USD 327.93 MM
INVENTORY TURNOVER RATIO(HY)
Highest at 2.97 times
DEBTORS TURNOVER RATIO(HY)
Highest at 3.82 times
OPERATING PROFIT(Q)
Highest at USD 74.2 MM
OPERATING PROFIT MARGIN(Q)
Highest at 58.23 %
PRE-TAX PROFIT(Q)
Highest at USD 63.39 MM
-13What is not working for the Company
INTEREST(HY)
At USD 1.82 MM has Grown at 8,979.04%
DEBT-EQUITY RATIO
(HY)
Highest at -7.75 %
RAW MATERIAL COST(Y)
Grown by 14.13% (YoY
Here's what is working for CorMedix, Inc.
Operating Cash Flow
Highest at USD 197.69 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Sales
At USD 127.43 MM has Grown at 63.52%
over average net sales of the previous four periods of USD 77.93 MMMOJO Watch
Near term sales trend is very positive
Net Sales (USD MM)
Net Profit
At USD 58.45 MM has Grown at 71.36%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
Operating Profit
Highest at USD 74.2 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Operating Profit Margin
Highest at 58.23 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at USD 63.39 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Pre-Tax Profit
At USD 63.39 MM has Grown at 67.75%
over average net sales of the previous four periods of USD 37.79 MMMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Cash and Eqv
Highest at USD 327.93 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Inventory Turnover Ratio
Highest at 2.97 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Debtors Turnover Ratio
Highest at 3.82 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Here's what is not working for CorMedix, Inc.
Interest
At USD 1.82 MM has Grown at 8,979.04%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Debt-Equity Ratio
Highest at -7.75 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Raw Material Cost
Grown by 14.13% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
